| Net Cash Provided by (Used in) Operating Activities |
$-66,269,427 |
USD |
-1,081.14% |
Q4 2024 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$5,884,978 |
USD |
|
Q4 2024 |
Q1 2025 |
| Common Stock, Shares Authorized |
5,000,000 |
shares |
0% |
Q2 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
2,723,709 |
shares |
0% |
Q2 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$7,270,519 |
USD |
-18% |
Q2 2025 |
Q3 2025 |
| Deferred Tax Assets, Valuation Allowance |
$19,400,000 |
USD |
-15.28% |
Q4 2024 |
Q1 2025 |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.04 |
pure |
0% |
Q4 2024 |
Q1 2025 |
| Operating Lease, Liability |
$190,743 |
USD |
-41.68% |
Q2 2025 |
Q3 2025 |
| Lessee, Operating Lease, Liability, to be Paid |
$231,491 |
USD |
-40.22% |
Q2 2025 |
Q3 2025 |
| Lessee, Operating Lease, Liability, to be Paid, Year Two |
$27,417 |
USD |
-83.04% |
Q2 2025 |
Q3 2025 |
| Lessee, Operating Lease, Liability, to be Paid, Year One |
$161,680 |
USD |
3% |
Q2 2025 |
Q3 2025 |
| Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
$40,748 |
USD |
-32.29% |
Q2 2025 |
Q3 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$13,900,000 |
USD |
|
Q2 2025 |
Q3 2025 |
| Interest Expense |
$9,563,000 |
USD |
49% |
Q2 2025 |
Q3 2025 |